Shire Plc (SHP)

Sector: Pharma and Biotech     Index: FTSE 100
0.28%
13.00p
4,734.50p
17:17 28/03/17
4,734.50p
17:17 28/03/17
DAILY VARIATION
0.28%
13.00p
VOLUME
2,548,531
REAL TIME BATS
4,731.50p
17:36 28/03/17
0.13%
6.00p
DATA
52 Week High
5,323.00p
52 Week Low
3,877.00p
Shares Issued
905.17m
Market Cap
£42,855.19m
RiskGrade
n/a
Beta
0.60
MENU

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.5% 0.6%
Div Cover 2.6 13.9
Op Mrgn 8.4% 36.1%
ROCE 12.1%
Latest F'cast
P/E 75.8 11.6
PEG -1.2 0.0
Pr/Revenue 4.7 3.5
Pr/Book 1.8
Latest F'cast
Revenue 77.6% 122.0%
PBT -65.5% n/a
EPS -65.6% 19.2%
DPS 15.0% 17.2%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 4,527.40 1,008.80 145.10¢ 21.1 -2.8 -8% 17.33¢ 0.6%
2013-12-31 4,934.30 1,697.50 257.20¢ 18.4 0.2 77% 19.93¢ 0.4%
2014-12-31 6,022.10 3,338.90 559.60¢ 12.6 0.1 118% 22.92¢ 0.3%
2015-12-31 6,416.70 1,383.60 227.00¢ 30.5 -0.5 -59% 26.37¢ 0.4%
2016-12-31 11,396.60 477.40 78.00¢ 74.0 -1.1 -66% 30.33¢ 0.5%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 12,289.25 4,434.00 404.26p 11.6 0.0 549% 29.00p 0.6%
2018-12-31 13,230.80 5,115.04 465.32p 10.1 0.7 15% 33.27p 0.7%

Newspaper Links

No results found